A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial

M.R. Mirza; L. Bjørge; F. Marmé; R. DePont Christensen; M. Gil-Martin; A. Auranen; B. Ataseven; M.J. Rubio; V. Salutari; B. Lund; I. Runnebaum; A. Redondo; K. Lindemann; F. Trillsch; M.P. Barretina Ginesta; H. Roed; J. Løhndorf; G-B. Nyvang; J. Sehouli

doi:10.1016/j.annonc.2020.08.2258

A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial

M.R. Mirza, L. Bjørge, F. Marmé, R. DePont Christensen, M. Gil-Martin, A. Auranen, B. Ataseven, M.J. Rubio, V. Salutari, B. Lund, I. Runnebaum, A. Redondo, K. Lindemann, F. Trillsch, M.P. Barretina Ginesta, H. Roed, J. Løhndorf, G-B. Nyvang, J. Sehouli

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	LBA28
Tidsskrift	Annals of Oncology
Vol/bind	31
Udgave nummer	Suppl. 4
Sider (fra-til)	S1160
ISSN	0923-7534
DOI	https://doi.org/10.1016/j.annonc.2020.08.2258
Status	Udgivet - 2020
Begivenhed	ESMO Virtual Congress 2020 - Virtual Varighed: 19 sep. 2020 → 21 sep. 2020 https://www.esmo.org/meetings/past-meetings/esmo-virtual-congress-2020

Konference

Konference	ESMO Virtual Congress 2020
Lokation	Virtual
Periode	19/09/2020 → 21/09/2020
Internetadresse	https://www.esmo.org/meetings/past-meetings/esmo-virtual-congress-2020

Adgang til dokumentet

10.1016/j.annonc.2020.08.2258

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Mirza, M. R., Bjørge, L., Marmé, F., Christensen, R. D., Gil-Martin, M., Auranen, A., Ataseven, B., Rubio, M. J., Salutari, V., Lund, B., Runnebaum, I., Redondo, A., Lindemann, K., Trillsch, F., Ginesta, M. P. B., Roed, H., Løhndorf, J., Nyvang, G-B., & Sehouli, J. (2020). A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial. Annals of Oncology, 31(Suppl. 4), S1160. Artikel LBA28 . https://doi.org/10.1016/j.annonc.2020.08.2258

@article{c583bbfdcfb14a538f2dbfcbd9b70c04,

title = "A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial",

author = "M.R. Mirza and L. Bj{\o}rge and F. Marm{\'e} and Christensen, {R. DePont} and M. Gil-Martin and A. Auranen and B. Ataseven and M.J. Rubio and V. Salutari and B. Lund and I. Runnebaum and A. Redondo and K. Lindemann and F. Trillsch and Ginesta, {M.P. Barretina} and H. Roed and J. L{\o}hndorf and G-B. Nyvang and J. Sehouli",

note = "Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020; ESMO Virtual Congress 2020 ; Conference date: 19-09-2020 Through 21-09-2020",

year = "2020",

doi = "10.1016/j.annonc.2020.08.2258",

language = "English",

volume = "31",

pages = "S1160",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "Suppl. 4",

url = "https://www.esmo.org/meetings/past-meetings/esmo-virtual-congress-2020",

}

Mirza, MR, Bjørge, L, Marmé, F, Christensen, RD, Gil-Martin, M, Auranen, A, Ataseven, B, Rubio, MJ, Salutari, V, Lund, B, Runnebaum, I, Redondo, A, Lindemann, K, Trillsch, F, Ginesta, MPB, Roed, H, Løhndorf, J, Nyvang, G-B & Sehouli, J 2020, 'A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial', Annals of Oncology, bind 31, nr. Suppl. 4, LBA28 , s. S1160. https://doi.org/10.1016/j.annonc.2020.08.2258

A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial. / Mirza, M.R.; Bjørge, L.; Marmé, F. et al.
I: Annals of Oncology, Bind 31, Nr. Suppl. 4, LBA28 , 2020, s. S1160.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC)

T2 - ESMO Virtual Congress 2020

AU - Mirza, M.R.

AU - Bjørge, L.

AU - Marmé, F.

AU - Christensen, R. DePont

AU - Gil-Martin, M.

AU - Auranen, A.

AU - Ataseven, B.

AU - Rubio, M.J.

AU - Salutari, V.

AU - Lund, B.

AU - Runnebaum, I.

AU - Redondo, A.

AU - Lindemann, K.

AU - Trillsch, F.

AU - Ginesta, M.P. Barretina

AU - Roed, H.

AU - Løhndorf, J.

AU - Nyvang, G-B.

AU - Sehouli, J.

N1 - Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020

PY - 2020

Y1 - 2020

U2 - 10.1016/j.annonc.2020.08.2258

DO - 10.1016/j.annonc.2020.08.2258

M3 - Conference abstract in journal

SN - 0923-7534

VL - 31

SP - S1160

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 4

M1 - LBA28

Y2 - 19 September 2020 through 21 September 2020

ER -

Mirza MR, Bjørge L, Marmé F, Christensen RD, Gil-Martin M, Auranen A et al. A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial. Annals of Oncology. 2020;31(Suppl. 4):S1160. LBA28 . doi: 10.1016/j.annonc.2020.08.2258